Natürliche humane IgM-Antikörper in der Therapie des Neuroblastoms: Vorläufige Ergebnisse einer Phase I/II-Therapiestudie
Caroline Schmitt(Universität Hamburg), R. Erttmann(Universität Hamburg), C. Löliger(Universität Hamburg), R Bredehorst(Universität Hamburg), Carl‐Wilhelm Vogel(Universität Hamburg), Jens Hiller(Universität Hamburg), Kerstin A. David(University of Hawaiʻi at Mānoa), Johanna Schrum(Universität Hamburg)
Cited by 4
Related Papers
Detection and quantification of mutations in the plasma of patients with colorectal tumors
|Proceedings of the National Academy of Sciences|2005|1.2k
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
|The Lancet|2012|376
Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision
|BioTechniques|2004|229
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients
|JAMA Neurology|2016|153
What establishes a protein as an allergen?
|Journal of Chromatography B Biomedical Sciences and Applications|2001|111